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Abstract
Pak1 (p21 activated kinase 1) is a serine/threonine kinase implicated in regulation of cell motility and survival and in
malignant transformation of mammary epithelial cells. In addition, the dynein light chain, LC8, has been described to
cooperate with Pak1 in malignant transformation of breast cancer cells. Pak1 itself may aid breast cancer development by
phosphorylating nuclear proteins, including estrogen receptor alpha. Recently, we showed that the LC8 binding site on
Pak1 is adjacent to the nuclear localization sequence (NLS) required for Pak1 nuclear import. Here, we demonstrate that the
LC8-Pak1 interaction is necessary for epidermal growth factor (EGF)-induced nuclear import of Pak1 in MCF-7 cells, and that
this event is contingent upon LC8-mediated Pak1 dimerization. In contrast, Pak2, which lacks an LC8 binding site but
contains a nuclear localization sequence identical to that in Pak1, remains cytoplasmic upon EGF stimulation of MCF-7 cells.
Furthermore, we show that severe developmental defects in zebrafish embryos caused by morpholino injections targeting
Pak are partially rescued by co-injection of wild-type human Pak1, but not by co-injection of mutant Pak1 mRNA disrupting
either the LC8 binding or the NLS site. Collectively, these results suggest that LC8 facilitates nuclear import of Pak1 and that
this function is indispensable during vertebrate development.
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Introduction
P21 activated kinase 1 (Pak1) is a serine-threonine kinase with
important roles in cytoskeletal dynamics and cell motility.
Increased Pak1 activity has been observed in advanced stages of
breast, brain, pancreatic, ovarian, and colon cancers [1]. Forced
expression of constitutively active Pak1 leads to increased
proliferation and anchorage-independent growth of MCF-7 cells,
a breast cancer cell line, whereas expression of a kinase dead Pak1
protein reduces the invasiveness of MDA-MB-435 breast cancer
cells [2]. Furthermore, in transgenic mouse models, expression of
activated Pak1 in breast epithelia is oncogenic, consistent with a
functional role of Pak1 in tumor progression [3].
Pak1 is activated by Cdc42 and Rac1, members of the small
GTPase family, and, in turn phosphorylates a wide range of
targets with diverse functions. For example, phosphorylation of the
estrogen receptor alpha by Pak1 at residue S305 increases its
transactivation potential in a ligand-independent manner [4].
Pak1 also phosphorylates T261 of ErbB3 binding protein 1 (Ebp1),
a transcriptional co-repressor that inhibits the growth of breast
cancer cells. Specifically, upon phosphorylation, the repressor
activity of Ebp1 is abolished, leading to increased proliferation of
breast cancer cell lines [5]. Although much attention has been
focused on roles of aberrant Pak1 activity in cancer, it has also
become clear that Pak1 has critical roles in normal cell physiology
and development, including mast cell function and the develop-
ment of the central nervous system [6–8]. It is, however, currently
poorly understood how different Pak1 phosphorylation events
affect cell fate decisions in different tissues and cell types. In
addition, while it is clear that Pak1 phosphorylates a large number
of cytoplasmic and nuclear targets, it is unclear how Pak1 shuttles
between cytoplasmic and nuclear locations.
In previous work, we [9] and others [10] have shown that Pak1
interacts with the dynein light chain, LC8, a small homodimeric
protein best known for its participation in the assembly of the
dynein motor complex. The LC8-Pak1 interaction has attracted
significant interest as both Pak1 and LC8 appear to be
coordinately upregulated in breast cancer specimens [10]. It has
been proposed that Pak1 phosphorylates LC8 at serine 88 and that
this event prevents BimL-dependent apoptosis in breast cancer by
affecting LC8-BimL dimers [10]. However, recent studies
demonstrated that the LC8-Pak1 interaction does not lead to
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6025LC8 phosphorylation, but rather represents a self-contained
tetrameric complex that forms independently of the dynein motor
protein [9]. Thus, the mechanism by which the LC8-Pak1
interaction affects either normal physiology or tumor development
remains uncertain.
Here, we addressed whether LC8 serves a role in nuclear import
of Pak1. This was based on the following observations and
considerations. Pak1 enters the nucleus of MCF-7 cells after EGF
stimulation, and among three potential nuclear localization
sequences (NLSs) present in Pak1, only one appears to be critical
for Pak1 nuclear import [11]. This site spans Pak1 residues 243–
245, and thus is in close proximity to the LC8 binding sequence,
which extends from residues 212–222 of Pak1 [9]. LC8 binding
has previously been shown to facilitate nuclear import of other
proteins, including the Rabies P protein and 53BP1 [12].
Although the molecular mechanism behind this function has
remained obscure, blocking the LC8 interaction abrogates nuclear
import of these targets [12]. We describe that (i) both the LC8
binding site and the NLS are required for nuclear import of Pak1
in breast epithelial cells, (ii) nuclear import of Pak1 by LC8
requires dimerization of the Pak1 NLS sequence and is
independent of LC8’s role in dynein transport, (iii) LC8-facilitated
nuclear import is specific to Pak1 and is not seen with other Group
1 Pak kinases, and (iv) LC8-mediated dimerization and nuclear
import functions of Pak1 are critically required for normal
vertebrate, i.e., zebrafish, development.
Results
LC8 Facilitates Pak1 Nuclear Import in MCF-7 cells
Previous studies have established that Pak1 translocates into the
nucleus upon EGF stimulation of MCF-7 breast cancer cells and
that EGF-induced nuclear import requires a weak nuclear
localization sequence consisting of residues 243 to 245 [11].
Further, LC8 has been shown to enhance nuclear import of both
the Rabies P protein and the p53 binding protein 53BP1 [12].
Finally, our recent structural and biochemical studies showed that
residues 212 to 222 of Pak1 encode an LC8 binding site adjacent
to the nuclear localization site (Fig. 1A) [9].
Collectively, these results led us to test whether nuclear import
of Pak1 depends on LC8 binding. We generated a double mutant
Pak1 (A218Q and T219E [LC8mut-Pak1]; see Fig. 1B) to
abrogate LC8 binding and tested whether these mutations would
affect Pak1 nuclear import. Wild-type (WT) and LC8mut-Pak1
constructs were tagged N-terminally with GFP or Myc sequences.
MCF-7 cells were transiently transfected with either GFP-WT-
Pak1 or GFP-LC8mut-Pak1 and stimulated with EGF for 25
minutes. We observed markedly lower levels of nuclear GFP-
LC8mut-Pak1 as compared to GFP-WT-Pak1 (Fig. 2). Co-
immunoprecipitation experiments using MCF-7 cells that coex-
pressed the Myc-Pak1 mutant and HA-LC8 verified that LC8mut-
Pak1 did not interact with LC8 whereas Myc-WT-Pak1 did (Fig.
S1A). To confirm the role of the NLS in EGF-dependent nuclear
import of Pak1, we mutated all three lysine residues in the Pak1
NLS sequence to alanines and evaluated nuclear Pak1 accumu-
lation upon EGF stimulation (Figs. 1B and 2). Similar to the
LC8mut-Pak1 construct, the NLS mutant, NLSmut-Pak1, also
showed much less EGF-stimulated nuclear accumulation (Fig. 2).
Quantitative analysis of Pak1 nuclear accumulation by confocal
microscopy revealed that 24% of the EGF-stimulated cells
transfected with GFP-WT-Pak1 contained GFP in the nucleus,
in contrast to only 8% or 10% of EGF-stimulated MCF-7 cells
transfected with the GFP-LC8mut or GFP-NLSmut Pak1
constructs, respectively. Unstimulated MCF-7 cells transiently
transfected with any of the three constructs contained GFP in less
than 1% of nuclei.
To confirm these results independently we prepared nuclear
and cytoplasmic fractions of the EGF-stimulated, transfected
MCF-7 cells and used immunoblot analysis to assess the GFP
content in these fractions. As expected, we did not detect GFP in
the nuclear extracts of cells expressing the LC8mut-Pak1 and
NLSmut-Pak1 constructs but observed comparable levels of
nuclear and cytoplasmic GFP in the WT-Pak1 expressing cells.
Western blot for GFP indicated that all GFP-Pak1 constructs were
expressed at comparable levels (Fig. S1B).
In previous work, we showed that LC8 preferentially binds to
dimeric targets [13]. Pak1 appears to be homodimeric when
inactive, with the inhibitory switch domain binding to the C-
terminal lobe of the Pak1 kinase domain, and positioning the
kinase inhibitory segment in the cleft of the kinase active site [14].
Upon binding of Cdc42 or Rac1 to the CRIB domain, this
inhibition is released, allowing Pak1 to autophosphorylate and
presumably become an activated, monomeric species [15]. In a
recent study, NMR and hydrodynamic studies showed that the
kinase domain of Pak2 (93% identity to the Pak1 kinase domain)
forms a homodimer; however, phosphorylation of the activation
loop renders a monomeric species [16]. Thus, it is not clear
whether the inactive or activated form of Pak1 binds LC8. To
Figure 1. Functional domains of Pak1 constructs relevant to LC8 interaction and nuclear import. (A) Schematic representation of the
domain structure of Pak1. The LC8 binding site and the nuclear localization sequence (NLS) shown to be critical for Pak1 nuclear import are
highlighted. (B) Mutants used for immunofluorescent experiments with MCF-7 cells and reconstitution experiments in zebrafish. Mutations of A218Q
and T219E in the LC8 binding site were generated to inhibit the LC8-Pak1 interaction and were based on the crystal structure 3DVP. The three lysine
residues in the NLS were mutated to alanines.
doi:10.1371/journal.pone.0006025.g001
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T423E, and tested whether LC8 was important for Pak1 nuclear
localization of this Pak1 variant. We observed that, similar to WT-
Pak1, the constitutively active form of Pak1 was cytosolic, but
translocated to the nucleus as soon as 20 min after EGF
stimulation (Figs. 2A and 2D). Co-immunoprecipitation experi-
ments revealed that the T423E/LC8mut Pak1 construct also does
not interact with LC8 (Fig. S1A). Mutation of the nuclear
localization sequence similarly reduced the nuclear accumulation
of constitutively active Pak1. Western blot analysis of cytoplasmic
and nuclear fractions from cells transiently transfected with
T423E-Pak1 constructs further established the requirement of
LC8 for Pak1 nuclear import (Fig. 2E).
LC8 Facilitates Pak1 Nuclear Import Independent of its
Association with Dynein
LC8 is frequently assumed to bridge cargo to the dynein motor
complex for retrograde transport, and the requisite binding of LC8
for nuclear import is consistent with dynein-mediated, retrograde
transport. However, our recent structural and thermodynamic
data suggest that LC8 regulates the function of its target proteins
in a dynein-independent manner [13]. Specifically, homodimeric
LC8 preferentially binds dimeric targets—either dynein or another
of its dimeric targets. Moreover, we recently showed that Pak1
binds to the same groove on the LC8 surface as the dynein
intermediate chain and that Pak1 binding to monomeric LC8 is
very weak (100 to 200 mM) [9]. Thus, to achieve an appreciable
concentration of the complex under physiological conditions, we
propose that a dimeric form of Pak1 must bind to a dimeric form
of LC8. We further propose that LC8 binds to and/or stabilizes a
conformation of Pak1 that is necessary for nuclear import and that
this event is independent of the function of LC8 in the dynein
complex.
To test this hypothesis and provide independent evidence that
LC8 induces a conformational change in Pak1, we turned to the
FKBP/AP20187 inducible dimerization system to mimic LC8
binding to Pak1 [17]. Specifically, we fused FKBP to the N-
terminal region of Pak1 that immediately follows the LC8 binding
region that encodes the nuclear localization sequenc http://www.
plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.
0004640e (residues 226–249) and to a similar construct that
includes this region as well as the kinase domain (residues 226–
545). In addition, we fused GFP to the N-terminus of FKBP to
facilitate examination of the subcellular localization of the
expressed constructs. All three constructs, GFP-FKBP-Pak1(226–
249), GFP-FKBP-Pak1(226–545), and a GFP-FKBP control were
transfected independently into MCF-7 cells and each construct
was located in the cytoplasm before the addition of a chemical
dimerizer, AP20187 (Fig. 3A). Upon the addition of AP20187 and
in the absence of EGF, a substantial fraction of both GFP-FKBP-
Pak1 products translocated to the nucleus within 25 min. The
level of nuclear localization for the shorter GFP-FKBP-Pak1(226–
249) construct was similar to that of the constitutively active, GFP-
T423E-Pak1 (32% vs. 34%, respectively). In addition, the nuclear
Figure 2. LC8 facilitates Pak1 nuclear import. (A) MCF-7 cells transiently transfected with either wild-type (WT), kinase active (T423E) GFP-Pak1,
Pak1-LC8mut or Pak1-NLSmut mRNA. Scalebar shown is 10 microns. Mutations of either the NLS or the LC8 binding sequence in WT-Pak1 or T423E-
Pak1 markedly reduced EGF-dependent nuclear import and stained with DAPI to visualize nuclei. (B) Quantification of nuclear accumulation of MCF-7
cells harboring either Pak1 or Pak1 mutants. Each bar represents percentage of cells with nuclear localized GFP (50 cells per experiment, done in
triplicate). (C) The fraction of GFP located in cytoplasmic (C) and nuclear (N) fractions of MCF-7 cells after stimulation with EGF. Potential cross
contamination of nuclear and cytoplasmic fractions was assessed by immunoblot analysis of Laminin A&C and Vinculin, respectively. (D) Nuclear
import of T423E-Pak1 mutants after EGF stimulation. Nuclear percentages were calculated as in B. (E) Western Blot analysis of cytoplasmic and nuclear
fractions of MCF-7 cells expressing T423E-Pak1 mutants after stimulation with EGF using an anti-GFP antibody.
doi:10.1371/journal.pone.0006025.g002
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after induction by AP20187 was comparable to that of GFP-WT-
Pak1 stimulated with EGF (24% in both experiments). These
results are consistent with the view that a specific Pak1 dimeric
conformation enabled by an LC8 dimer or LC8 surrogate (i.e.,
FKBP) regulates Pak1 nuclear import in a dynein-independent
fashion.
LC8 interaction is unique to Pak1 in the Pak family
The Pak family of kinases consists of six members divided into
two groups, Group 1 and Group 2 Paks [18]. This classification is
based on structural and sequence similarities and functional
differences between the six kinases. Pak1, Pak2 and Pak3
encompass the Group 1 Pak kinases, and all three members
contain an auto-inhibitory domain, which is released upon binding
of Cdc42/Rac1 to the CRIB domain, and a b-PIX binding site, an
interaction previously shown to be important for Pak activation
[19]. Each member also encodes an NLS sequence immediately
preceding the kinase domain; however, Pak1 and Pak2 contain
identical NLS sequences consisting of three sequential lysine
residues (Fig. S2A). The C-terminal region of Pak2 (213–524) can
translocate into the nucleus after cleavage by Caspase 3 in
Figure 3. Pak1 nuclear import is contingent upon LC8 dimerization and is dynein independent. (A) Confocal microscopy images of MCF-
7 cells transiently transfected with either the FKBP vector, Pak1 226–249, or Pak1 226–545 show either GFP-Pak1 construct is cytoplasmic in the
absence of AP20187 and stained with DAPI to visualize nuclei. Scalebar shown is 10 microns. (B) Quantification of confocal images indicates an ,5
fold increase in nuclear GFP over non-treated cells upon AP20187 treatment. Data quantified in the same manner as in Fig. 2B.
doi:10.1371/journal.pone.0006025.g003
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identified in the cytoplasm. The Group 2 Paks differ from Group 1
Paks in that the NLS signal is located at the far N-terminus, and
they lack a b-PIX binding site [21]. We did not observe a
definitive LC8 binding site in Group 2 Paks.
Because Pak2 can also translocate to the nucleus, we generated
a GFP-Pak2 construct and tested whether EGF stimulation of
transfected MCF-7 cells led to its nuclear accumulation. GFP-Pak2
was entirely cytoplasmic, and remained cytoplasmic when treated
with EGF as in the GFP-Pak1 experiments (Fig. S2B). Of note,
apoptotic events that activate Caspase 3 lead to the cleavage of
Pak2 between residues 212 and 213, and only the C-terminal Pak2
fragment that contains the NLS and the kinase then translocates to
the nucleus [20]. Although MCF-7 cells are Caspase 3-deficient
and the GFP protein was fused to the N-terminus of Pak2, we
immunoblotted for GFP before and after stimulation with EGF
and showed that Pak2 is not cleaved in these experiments (Fig.
S2C).
Collectively, these results indicate that LC8 specifically interacts
with and enhances nuclear import of Pak1, but not Pak2, in EGF-
stimulated cells. Furthermore, Pak3, although highly homologous
to the other Group 1 Pak members, does not contain a clear LC8
binding site and we predict that its nuclear localization is not LC8
dependent.
Pak1 nuclear import is critical for survival and
development
Elevated expression levels of Pak1 and LC8 in tumor tissues and
growth of MCF-7 cells overexpressing Pak1 and LC8 in soft agar
assays suggest that the LC8-Pak1 interaction is critical for tumor
progression. Pak1 has also been shown to phosphorylate nuclear
targets, including estrogen receptor alpha, PFK-M and SHARP,
consistent with a role of nuclear Pak1 in disease progression [1,11].
However, it is not clear whether the LC8-Pak1 interaction is
relevant or necessary under physiological conditions. To address
this question, we turned to zebrafish as a model organism. The
Pak1 orthologue in zebrafish has 81% sequence identity and 87%
sequence conservation with the human Pak1 protein. In addition,
the LC8 binding site in the zebrafish Pak1 protein has 73%
sequence identity and 91% sequence conservation with the human
Pak1 protein (Fig. S3A). Of particular importance is an aspartate
at the identical position in the LC8 binding region in both the
zebrafish and human Pak1 proteins. Our previous studies indicate
this specific aspartate interacts with an absolutely conserved
hydrogen bond network in LC8 and is critical for the stability of
the LC8-Pak1 interaction [9]. Finally, the zebrafish LC8 sequence
is 93% identical and 98% similar to human LC8.
To determine the effect of Pak1 knockdown, we designed a
Pak1-specific morpholino that targets Pak1 mRNA sequences
surrounding the ATG start codon. We first injected 60 fertilized
embryos with the Pak1 morpholino (MO1) (concentrations
ranging from 0.125 to 2 mM) and observed a decreased rate of
survival and morphological alterations in surviving embryos
associated with increasing concentrations of MO1 compared to
the normal mock-injected embryos. Differences were seen as early
as 24 hours post-fertilization (hpf) and included smaller heads and
eyes, shorter body lengths, and, by 48 hpf, pericardial edema. At
96 hpf, these malformations progressed to include curled tails,
marked pericardial edema, and gross morphological defects in the
heart (Fig. 4A). By measuring the length of the body axis, we
observed statistically significant (p,0.05) reductions in overall
body length in Pak1 MO-injected fish when compared to
uninjected embryos. Using the transgenic line Tg:VEGFR2-
GRCFP [22], we further observed impaired, delayed angiogenesis
in embryos injected with MO1. Specifically, lumen formation of
intersegmental vessels was markedly reduced, leading to visibly
reduced blood flow in the trunk and tail (data not shown). It
remains to be investigated whether these abnormalities reflect a
functional role of Pak1 in angiogenesis or occur secondary to
impaired heart development.
Several control experiments were performed to ascertain
whether the effects observed were specific to Pak1 knockdown.
First, we designed a second morpholino that targets a different
sequence in zebrafish Pak1 mRNA, a 59 intron/exon splice site
(MO2). As expected, injecting embryos with MO2 (0.5–1 mM)
markedly reduced viability and led to aberrations in body axis
development and pericardial edema in a fashion similar to the
ATG-targeted Pak1 MO1 (Fig. S3B). In addition, we attempted to
rescue developmental defects caused by Pak1-targeted MOs by co-
injecting Pak1 mRNA. In these experiments, we used human Pak1
mRNA because there is significant sequence identity and similarity
between the zebrafish and human orthologs. Embryos injected
with both Pak1 MO1 and hPak1 mRNA showed a 53% survival
rate compared to the 28% survival rate of MO1-only injected fish
(Fig. 4B). Significantly, 80% of the surviving co-injected fish were
morphologically indistinguishable from the control fish. On the
other hand, all surviving MO1-only injected embryos showed
extensive pericardial edema and other malformations by 4 dpf
(Fig. 4D).
To distinguish putative roles of Pak1 nuclear import in vivo,w e
generated mRNA of the nuclear import deficient mutants and co-
injected embryos with mutant mRNAs and Pak1 MO1 at the same
concentration as the WT-Pak1 recovery experiments. Embryos
were injected with Pak1 MO1 and either NLSmut-Pak1 or
LC8mut-Pak1 mRNA. Neither mRNA was able to rescue the
phenotype associated with Pak1 MO1 injection (Fig. 4A). Embryos
injected with NLSmut-Pak1 mRNA had a 28% survival rate at
4 dpf, similar to that of the group injected with MO1 alone
(Fig. 4B). Furthermore, embryos injected with LC8mut-Pak1
mRNA had an 18% survival rate, further indicating that the LC8-
Pak1 interaction is necessary during development.
Next, we examined the effects of overexpressing human Pak1 in
zebrafish embryos. Injection of hPak1 mRNA alone led to death
and/or severe morphological aberrations in the injected embryos.
Interestingly, these were similar to the aberrations observed in fish
treated with Pak1-targeted MOs, and mainly consisted of
aberrations in body axis development and pericardial edema.
However, embryos singly injected either with the human NLSmut-
or LC8mut-Pak1 mRNA showed very few morphological
alterations, consistent with the view that deleterious effects of
Pak1 overexpression on zebrafish morphology and survival
depend on nuclear import (Figs. 5A and B). Western blot analysis
using a Pak1 specific antibody verified that all three groups of
human Pak1 mRNA injected fish expressed similar levels of Pak1
protein (Fig. 5C). In aggregate, these results support a crucial role
of nuclear import of Pak1, facilitated by LC8, in development and
survival of zebrafish embryos.
Discussion
The evidence presented here supports the following conclusions:
(i) nuclear import of Pak1 requires interaction with LC8, (ii) this
interaction occurs independently of the LC8/dynein interaction,
(iii) among the Pak family members, this function is specific to
Pak1, and (iv) LC8-mediated nuclear import of Pak1 is essential
during development of zebrafish embryos.
We previously reported that LC8 and Pak1 form a dimer of
dimers and that Pak1 binding precludes simultaneous interaction
Nuclear Import of Pak1
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Previous studies by others have shown that Pak1 exists as a
homodimer when inactive [14]. The results presented here extend
this concept, and suggest that activated Pak1 similarly exists in a
dimeric state enabled, at least in part, by interaction with LC8.
This finding was surprising as it has been shown that Cdc42 binds
to the inactive and presumably dimeric Pak1, permitting its
autophosphorylation and producing an active monomeric state
[15]. Similarly, recent NMR studies of the Pak2 kinase domain
indicate that the non-phosphorylated kinase also forms a
homodimer; however, phosphorylation of the activation loop
produces a monomeric kinase [16]. Notwithstanding these earlier
reports, our results are consistent with the view that at least a
fraction of activated Pak1 is dimeric and that this dimeric state is
stabilized, in part, by LC8 interaction.
These observations raised the question whether LC8-bound
dimeric Pak1 has any identifiable functions in cell biology. Here,
we provide evidence that dimerization of Pak1 enabled by
sequences N-terminal to the NLS promotes the nuclear import
of Pak1. Specifically, the short fragment of Pak1 containing the
NLS sequence (residues 226–249), when fused to FKBP in place of
the LC8 binding domain, remained cytosolic despite being
unencumbered by steric restraints from the remaining domains
of wild-type Pak1. However, upon dimerization by adding
AP20187, this short fragment immediately dimerized and
translocated to the nucleus of MCF-7 breast cancer cells. This is
consistent with the hypothesis that the dimeric state of Pak1,
recognized by LC8, is necessary to create a ‘bipartite’ NLS
complex recognizable by an importin. This situation is not without
precedent, as biochemical and structural studies have shown that
nuclear localization of the Stat family members and SREBP-2
similarly requires dimerization [23,24].
Taken together, these observations suggest that EGF-induced
nuclear localization of Pak1 requires a significant conformational
change accompanying the transition from the inactive-to-active
state, dimerization through LC8-binding sequences in close
proximity to the NLS, and alignment of weak NLS signals in
Pak1 monomers through LC8-dependent orientation followed by
importin recognition and nuclear import (Fig. 6).
To better understand functional implications of Pak1 nuclear
import, we turned to zebrafish embryos as a facile vertebrate
model system. First, we established by use of Pak1-targeted
antisense oligonucleotides that Pak1 expression is essential for
normal development of zebrafish. Second, we demonstrated that
human Pak1 mRNA partially rescued embryonal lethality and
embryonal malformations caused by Pak1 knockdown. Third, we
observed that mutating either the LC8 binding site or the NLS site
abrogated the capacity of human Pak1 to rescue the defects caused
by zebrafish Pak1 knockdown. While it is currently unclear which
target cells and tissues are responsible for the phenotypes caused
by Pak1 knockdown, these results provide strong, independent
evidence that LC8-mediated Pak1 nuclear import has a central
role in zebrafish development and potentially in mammalian cells
and tissues. This role goes beyond the regulation of estrogen
receptors, as previously reported [4], and suggests that additional
nuclear Pak1 targets are involved in development.
In conclusion, this study provides the first evidence that Pak1,
localized in the nucleus, has an essential role in development. It
Figure 4. Pak1 nuclear import is critical for zebrafish development and survival. (A) Representative images of zebrafish embryos at 4 dpf.
Embyros were co-injected with the morpholino (MO1) and either human wt-Pak1 mRNA, human Pak1-NLSmut or human Pak1-LC8mut (last three
panels). Uninjected embryos and MO1 only injected embryos are also shown. (B–D) Quantitative analysis of differential zebrafish survival, body
length, and extent of cardiac edema at 4 dpf in embryos injected with different morpholino/Pak1 mRNA combinations. For B, percent survival of
uninjected control fish is approximately 90%. For D, cardiac edema for experimental fish was normalized to the control fish.
doi:10.1371/journal.pone.0006025.g004
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among other signal transducers has functionally significant
consequences for nuclear import and that LC8 plays an essential
role in stabilizing Pak1 dimerization.
Materials and Methods
Materials
Anti b-Actin, anti-GFP, anti-Laminin A/C, anti-Myc, and anti-
HA antibodies were purchased from Santa Cruz Biotechnology.
Anti-Vinculin and anti-Pak1 antibodies were from Cell Signaling.
EGF and the anti-b tubulin antibody were from Sigma. The Pak1
morpholino (MO) (GeneTools, LLC) was designed to target the
ATG start site (59-CCTCTACTTCCCCATTGTCTGACAT-39).
A second MO, MO2, was designed to target the Pak1 59 intron/
exon splice site (59-GCATCACTCACTCTTGTCTCCTC-39).
Expression Plasmids and Transfection
Pak1 (Accession Number: NP 002567) was subcloned into
pEGFP-C1 vector (Clontech) and pCS2 vector (Dave Turner,
University of Michigan). The Pak1 mutants (K299R, T423E,
LC8mut, and NLSmut) were generated using the Quikchange site
directed mutagenesis kit (Stratagene). The FK506 binding protein
(FKBP) gene and Pak1 226–249 or Pak1 226–545 were cloned
into pEGFP-C1-FKBP vector. For transient expression, cells were
transfected using Lipofectamine (Invitrogen).
Figure 5. Overexpression of human Pak1 produces embryonic abnormalities in zebrafish that are contingent upon nuclear import
of Pak1. (A) Images of zebrafish embryos at 4 dpf. Embryos were injected with either Pak1 WT-mRNA or one of the mRNA of the Pak1 nuclear import
mutants (80 ng/mL). (B) Quantitative analysis of differential zebrafish body axis malformation at 4 dpf in embryos injected with either Pak1 WT-mRNA
or one of the mRNA of the Pak1 nuclear import mutants. (C) Immunoblot analysis of lysates from zebrafish injected with either human Pak1-WT,
NLSmut, or LC8mut mRNA.
doi:10.1371/journal.pone.0006025.g005
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MCF-7 human breast cancer cells on glass coverslides (Fisher) at
1610
6 cells per 6-well tissue culture plate were transfected with
vectors containing different Pak1-GFP constructs. After 24 h, cells
were serum starved for 14–16 h before being stimulated with EGF
(100 ng) for 20 min. For the FKBP experiments, cells were treated
with AP20187 (100 nM, Ariad) in serum-free media for 30 min.
Cells were fixed with 4% paraformaldehyde and nuclei were
counterstained with 49,6-diamidino-2-phenylindole (DAPI; Sig-
ma).
Cell Fractionation, Western Blotting and Co-
Immunoprecipitation
Cellular fractionation experiments were performed as previous-
ly described [25], MCF-7 cells in 10 mm plates were transfected
with 5 mg Myc-Pak1, or Pak1 mutants, and 5 mg HA-human LC8
for co-immunoprecipitation experiments and. Cells were lysed,
loaded on Protein A agarose beads, washed and separated on
reducing SDS-PAGE gels. Gels were immunoblotted with the
corresponding antibody.
Zebrafish experiments
Maintenance of zebrafish stocks and embryo collection were
carried out following standard procedures [26] and with approval
by the Institutional Animal Care and Use Committee at Thomas
Jefferson University. Morpholino experiments were performed as
previous described (see supplemental data) [27], Fisher’s Exact
Test was performed using a sample sizes of n=120 embryos per
condition. The p value was set for less then 0.001 with a 95%
confidence interval.
Additional details are provided in the supplemental (Methods
S1).
Supporting Information
Methods S1 Extended methods and supplemental figure
captions
Found at: doi:10.1371/journal.pone.0006025.s001 (0.08 MB
PDF)
Figure S1 Binding assays and expression of Pak1 constructs (A)
Co-immunoprecipitation of whole cell lysates overexpressing HA-
LC8 and Myc-Pak1, and associated mutants. Results indicate
mutation of the LC8 binding site in Pak1 abrogates the
interaction. (B) Western blot of GFP-Pak1 constructs in MCF-7
cells.
Found at: doi:10.1371/journal.pone.0006025.s002 (0.28 MB
PDF)
Figure S2 Pak2 is not cleaved after EGF Stimulation. (A)
Sequence alignment of Group1 Pak kinases, highlighting that the
Pak1 LC8 binding site (boxed) is absent in Pak2 and Pak3. By
contrast, Pak1 and Pak2 share identical nuclear localization
sequences (NLS) positioned at the same location upstream of the
kinase domain. (B) Representative examples of subcellular
distribution of Pak2 as determined by confocal microscopy. Pak2
does not translocate to the nucleus after EGF stimulation in MCF7
cells. (C) Western blot of MCF7 cells expressing either GFP alone
or GFP-Pak2 before and after stimulation with EGF. Results show
GFP runs at the same molecular weight after EGF treatment,
showing that Pak2 is not cleaved in these experiments.
Found at: doi:10.1371/journal.pone.0006025.s003 (0.42 MB
PDF)
Figure S3 Zebrafish Pak1 Protein and Rescue. (A) Sequence
alignment of Human and Zebrafish Pak1 protein. (B) Pak1
knockdown with a Pak1 MO to the 59 intron/exon splice site
(MO2) showed phenotypes identical to the Pak1 MO for the initial
ATG codon. Co-injection of human Pak1 mRNA was able to
recover the phenotype. Pictures were taken at a 12.56
magnification. (C) Quantification of zebrafish survival at 4 dpf in
embryos injected with Pak1 MO2 and embryos rescued with
human Pak1 wt-mRNA.
Found at: doi:10.1371/journal.pone.0006025.s004 (0.30 MB
PDF)
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Figure 6. Model of Pak1 translocation. Pak1 is a stable homodimer in its inactive state. Multiple signals from different pathways (GPCRs, RTKs,
and lipids) act on Pak1 and activate it. One potential pathway suggests that the N-terminus of Pak1 binds to Nck or Grb2, which is associated with the
activated EGFR. This permits Cdc42/Rac1 to bind to Pak1, allowing it to trans-autophosphorylate. We propose this permits LC8 binding, which
localizes the weak NLS to act as a bipartite ligand for importin binding and ultimately nuclear translocation.
doi:10.1371/journal.pone.0006025.g006
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